Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01213706 · ClinicalTrials.gov registry record · NA
Effect of Whole Body Periodic Acceleration on Airway Endothelial Function
A NA study of Healthy and Asthma, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT01213706: Completed NA study of Healthy and Asthma, sponsored by University of Miami.
NCT01213706 is a NA study of Healthy and Asthma that has completed, run by University of Miami. The registered enrollment target is 45 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01213706, a NA study of Healthy and Asthma, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
In the present proposal the investigators wish to assess the effect of a single session with the device known as Exer-Rest® which applies Whole Body Periodic Acceleration (WBPA) on baseline airway blood flow (Qaw) and in Qaw variation, in current smokers, glucocorticoid-naïve asthmatics, and age-matched healthy never-smokers, with the expectation that the treatment will transiently increase the Qaw, and to a greater extent in the current smokers and patients with asthma who have endothelial dysfunction.
Primary Outcome
Airway Blood Flow will be measured before and 15 minutes after the 180 mcg of albuterol inhalation.
Interventions
- DEVICE Whole Body Periodic Acceleration (WBPA)
- DEVICE Sham WBPA
Study Locations (1)
Florida
- Pulmonary Human Research Laboratory, University of Miami Miller School of Medicine - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2009-10 |
| Est. Completion | 2011-05 |
| Phase | NA |
What the finished NCT01213706 record still lists
NCT01213706 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (93% lower).
The record links to 3 conditions, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Whole Body Periodic Acceleration (WBPA) is the first listed.
NCT01213706 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT01213706 about?
NCT01213706 is a clinical study titled "Effect of Whole Body Periodic Acceleration on Airway Endothelial Function". In the present proposal the investigators wish to assess the effect of a single session with the device known as Exer-Rest® which applies Whole Body Periodic Acceleration (WBPA) on baseline airway blood flow (Qaw) and in Qaw variation, in current smokers, glucocorticoid-naïve asthmatics, and age-mat...
What is the current status of trial NCT01213706?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2009-10. Estimated completion is 2011-05.
What conditions does trial NCT01213706 study?
This clinical trial studies the following conditions: Healthy, Asthma, Smokers.
What interventions are being tested in trial NCT01213706?
The interventions under investigation include: Whole Body Periodic Acceleration (WBPA) (DEVICE), Sham WBPA (DEVICE).
Who is sponsoring clinical trial NCT01213706?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01213706 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01213706's enrollment target sits among peer trials
45 500th of 1090 higher than 586 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study
RECRUITING · NA
-
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
RECRUITING · NA
-
Medical Illustration Design Characteristic Evaluation
RECRUITING · NA
-
Sodium vs Potassium Education to Improve Vascular Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia